Original price was: $100.00.$60.00Current price is: $60.00.
Compound: Tesamorelin (Modified GHRH 1–44)
Amount: 10mg per vial
Format: Lyophilized Powder
Chemical Classification: Synthetic 44-Residue GHRH Analog
Research Category: Growth Hormone-Releasing Hormone Receptor (GHRHR)
Chemical Profile: Tesamorelin is a synthetic analog of the 44-residue human growth hormone-releasing hormone sequence. It contains an N-terminal trans-3-hexenoyl modification. Researchers investigate its peptide structure and interactions with the GHRH receptor in laboratory systems.
Research Use Only. Not for human or veterinary use.
Monthly subscription three vials of 10mg for a total of 30mg was $180 now $140
Tesamorelin is a synthetic growth hormone-releasing hormone analog containing 44 amino-acid residues. A trans-3-hexenoyl group modifies the peptide’s N-terminus.
The compound is studied in the GHRH receptor family and in comparisons of modified peptide structures. Its sequence length differs from the shorter GHRH(1–29) peptide known as sermorelin.
| Specification | Details |
|---|---|
| Compound | Tesamorelin (Modified GHRH 1–44) |
| Synonyms | Modified GHRH(1–44) |
| Classification | Synthetic Acylated GHRH Analog |
| Length | 44 Amino Acids |
| Sequence | trans-3-hexenoyl-GHRH(1–44)-NH2 |
| Molecular Formula | C221H366N72O67S |
| Molecular Weight | Approximately 5,136 g/mol |
| CAS Number | 218949-48-5 |
| Form | Lyophilized Powder |
| Amount | 10mg per vial |
| Intended Use | Laboratory Research Only |
trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2
Tesamorelin is a 44-residue GHRH analog with an N-terminal hexenoyl group. Sermorelin corresponds to an amidated 29-residue N-terminal GHRH fragment. Their sequence lengths and chemical modifications distinguish the two peptides.
Tesamorelin is a peptide ligand associated with the growth hormone-releasing hormone receptor (GHRHR). Scientists examine how GHRH-related molecules interact with this receptor. Comparative receptor research considers the peptide identity and assay environment.
The native GHRH sequence contains 44 amino-acid residues. Tesamorelin retains the GHRH-related chain and adds an N-terminal modification. This structural design is relevant to studies of peptide chemistry and sequence recognition.
The trans-3-hexenoyl group is a defining part of Tesamorelin’s identity. Researchers characterize this modification when comparing peptide analogs. The same GHRH sequence with and without an appended chemical group represents a different molecular preparation.
Sermorelin and Modified GRF(1–29) are shorter GHRH-related peptides. Researchers compare these compounds with longer GHRH sequences to characterize differences in structure and receptor interactions. Sequence length and terminal chemistry matter to each comparison.
GHRHR is a G-protein-coupled receptor associated with intracellular second-messenger signaling. In experimental systems, researchers measure binding and signaling responses to GHRH-related ligands. These assays provide mechanistic information about the tested molecular forms.
Certificates of Analysis (COAs) are posted on the product page when available. To request documentation for a specific lot, contact the Genoscience team with the lot number.
Store unopened lyophilized research material at −20 °C in a dry environment, protected from light and moisture. Allow the sealed vial to reach room temperature before opening to reduce condensation.
Handle using suitable laboratory protective equipment and standard research-facility procedures.
Research Use Only: This product is intended strictly for laboratory research and development.
Not for Human or Veterinary Use: Not intended for human consumption, administration or veterinary applications.
Not an Approved Medicine: This material is not marketed as an FDA-approved drug or treatment.
Research Limitations: Laboratory and preclinical findings do not establish clinical safety or efficacy for this product.
Tesamorelin is a modified 44-residue GHRH analog with an N-terminal hexenoyl group.
It is a 44-residue GHRH-related peptide with a trans-3-hexenoyl N-terminal modification.
Tesamorelin contains 44 residues and a chemical N-terminal modification. Sermorelin is the amidated 29-residue GHRH fragment.
Tesamorelin is associated with GHRHR. Ipamorelin is associated with the growth hormone secretagogue receptor GHSR-1a.
Genoscience lists 10mg of lyophilized Tesamorelin per research vial.
When available, the COA for Tesamorelin 10mg can be found on the product page. You may also contact Genoscience to request a COA for a specific lot.
No. Genoscience sells Tesamorelin 10mg strictly for laboratory research purposes. It is not intended for human or veterinary use.
Original price was: $70.00.$50.00Current price is: $50.00.
Original price was: $350.00.$220.00Current price is: $220.00.
Original price was: $150.00.$115.00Current price is: $115.00.
You must be at least 21 years old to enter Genoscience and review products intended for laboratory research use only.
Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.
